Affiliation:
1. Department of Chemistry, The University of Sistan and Baluchestan, P. O. Box 98135-674, Zahedan,Iran
Abstract
Aims and Objective:
The main objective of the kinetic investigation of the reaction between ethyl
acetoacetate 1, ammoniumacetat 2, dimedone 3, and diverse substitutions of benzaldehyde 4-X, (X= H, NO2, CN,
CF3, Cl, CH (CH3)2, CH3, OCH3, OCH3, and OH) for generating 4-substituted 1, 4-dihydropyridine derivatives
(product 5) was to recognize the most realistic reaction mechanism. The layout of the reaction mechanism was
studied kinetically via a UV-visible spectrophotometry approach.
Materials and Methods:
Among the various mechanisms, only mechanism1 (path1) involving 12 steps was recognized
as a dominant mechanism (path1). Herein, the reactions between 1 and 2 (kobs= 814.04 M-1.min-1) and also
between 3 and 4-H (kobs= 151.18 M-1.min-1) can be accepted as the first and second steps (step1 and step2) of
the reaction mechanism, respectively. Amongst all steps, only step9 of the dominant mechanism (path1) comprised
substituent groups (X) near the reaction center.
Results and Discussion:
Para electron-withdrawing or donating groups on the compound 4-X increased the rate
of the reaction 4 times more or decreased 8.7 times less than the benzaldehyde alone. So, this step is sensitive for
monitoring any small or huge changes in the reaction rate. Accordingly, step9 is the rate-determining step of the
reaction mechanism (path1).
Conclusion:
The recent result is in agreement with the Hammett description of an excellent dual substituent factor
(r = 0.990) and positive value of reaction constant (ρ= +0.9502), which confirms that both the resonance and
inductive effects “altogether” contribute to the reaction center of step9 in the dominant mechanism (path1).
Publisher
Bentham Science Publishers Ltd.
Subject
Organic Chemistry,Biochemistry
Reference111 articles.
1. Godfraind T.; Miller R.; Wibo M.; Calcium antagonism and calcium entry blockade. Pharmacol Rev 1986,38(4),321-416 http://pharmrev.aspetjournals.org/content/38/4/321
2. R.; SILVER, P.; TRIGGLE, D. Drug action and cellular calcium regulation. Adv Drug Res 1987,16,309-591
3. Mager P.P.; Coburn R.A.; Solo A.J.; Triggle D.J.; Rothe H.; QSAR, diagnostic statistics and molecular modelling of 1,4-dihydropyridine calcium antagonists: a difficult road ahead. Drug Des Discov 1992,8(4),273-289
4. Sausins A.E.; Duburs G.; Synthesis of 1, 4-dihydropyridines in cyclocondensation reactions. Chem Heterocycl Compd 1992,28(4),363-391
5. Mannhold R.; Jablonka B.; Voigt W.; Schönafinger K.; Schraven E.; Calcium- and calmodulin-antagonism of elnadipine derivatives: comparative SAR. Eur J Med Chem 1992,27(3),229-235